Fresh capital will push DF-003 through Phase 3 for the rare inflammatory disorder ROSAH syndrome and DF-006 through Phase 2 in hepatitis B and liver cancer
Newsflash:
The Trump administration’s pick for Assistant Secretary for Preparedness and Response has a history of linking hepatitis …
Fresh capital will push DF-003 through Phase 3 for the rare inflammatory disorder ROSAH syndrome and DF-006 through Phase 2 in hepatitis B and liver cancer
The Trump administration’s pick for Assistant Secretary for Preparedness and Response has a history of linking hepatitis …
Fresh capital will push DF-003 through Phase 3 for the rare inflammatory disorder ROSAH syndrome and DF-006 through Phase 2 in hepatitis B and liver cancer
The Trump administration’s pick for Assistant Secretary for Preparedness and Response has a history of linking hepatitis …
LEADERS
INVESTMENTS
INNOVATION
PARTNERSHIPS
In-Depth Analysis
In-Depth Analysis
Explore our longform features and deep dives into biotech breakthroughs and innovation.
Expert Opinions
Expert Opinions
Read opinions and commentary from leading scientists, investors, and pharma leaders.
Funding & IPOs
Funding & IPOs
Track the latest funding rounds, IPO announcements, and investment trends in biotech/pharma.
Clinical Results & Milestones
Clinical Results & Milestones
Stay informed on pivotal trial results, FDA approvals, and key clinical milestones.
1
2
3
4
5
6
7
8
9
10
1
2
3
4
5
6
7
8
9
10
The Reporter Newsletter
Expert picks and exclusive deals, in your inbox.
BlueRock Therapeutics reports that a single transplant of dopaminergic progenitors derived from pluripotent stem cells produced durable reductions in motor disability in Parkinson’s patients, with Phase 3 enrolment underway
BlueRock Therapeutics reports that a single transplant of dopaminergic progenitors derived from pluripotent stem cells produced durable reductions in motor disability in Parkinson’s patients, with Phase 3 enrolment underway
Watch Now
Depot blast in Bangladesh kills nearly 50 people - BBC News
Russia accused of stealing about 600,000 tonnes of Ukraine's grain - BBC News
Devastation of Australia's climate change crisis captured on camera - BBC News
Boris Johnson survives leadership vote but 41% of his MPs have “no confidence” - BBC News
The Trump administration’s pick for Assistant Secretary for Preparedness and Response has a history of linking hepatitis B vaccination to …
Major investment strengthens pharmaceutical supply chain resilience and advances green manufacturing practices in North America.
Listen Now
December 18 brings a milestone for cell therapy in graft-versus-host disease—and a setback for Duchenne muscular dystrophy research, highlighting the regulatory tightrope in advanced therapeutics.
New PMN310 data presented in London show measurable drops in cerebrospinal fluid amyloid-beta oligomers at three and 29 days after dosing, as Biogen also unveils mid-stage tau data at the same conference
Triple-drug combination extending life for women with aggressive HR+/HER2− breast cancer
Data presented at AAIC 2026 tie SEMA4D blockade to regulation of astrocyte biomarkers linked to disease progression, as the company scopes an enlarged SIGNAL-AD2 trial
Ready To Explore Industry News?
All articles are free -no payment or registration required.
Already a subscriber?